United voices for prime GU cancer care: Specialists to convene at EMUC25
For nearly two decades, the congresses of the European Multidisciplinary Congress on Urological Cancers (EMUC) have upheld their reputation as the prime platform for interdisciplinary approaches on genitourinary (GU) treatment.
Curious about the scientific content at the upcoming 17th edition of EMUC (EMUC25)? The Steering Committee Members offer you a preview of some of the congress highlights in this article.
Not only for urologists
The EMUC scientific programme is also consistently relevant, timely, and beneficial to a broad range of specialists.
“Although urologists traditionally attend EMUC, the faculty and participants comprise medical oncologists, radiation oncologists, nuclear medicine radiologists, pathologists, and other experts who are involved in the care of GU cancer patients. This results in fruitful discussions and, of course, well-rounded solutions,” said Dr. Elena Castro (ES), a Steering Committee Member representing the European Society for Medical Oncology (ESMO).
She added, “Multidisciplinarity is what scientific societies believe should guide the care of patients with GU tumours.”
Content for every GU cancer care specialist
Prof. Arnulf Stenzl (DE), Secretary General of the European Association of Urology (EAU), highlighted the sessions that cover the role of artificial intelligence in supporting patients’ journeys. He said, “The discussions about imaging helping to avoid biopsy in urological cancers will be interesting for clinicians. The session on hereditary GU cancers will also be a key highlight for those who seek answers in this complex thematics.”
Dr. Alison Tree (GB) of the European SocieTy for Radiotherapy and Oncology (ESTRO) also shared more topics to look forward to at EMUC25.
“A topic that will be interesting to explore is how to make the future of GU oncology care sustainable while treating patients more effectively and efficiently. Participants can also enjoy learning from multi-disciplinary viewpoints during the case discussions on rare and unconventional pathologies, to learn more about the “Cinderella tumours”.
“In addition, the Game-Changing Session on the CREST, AMPLITUDE metastatic HSPCa, and PACE trials is a must-attend,” stated Dr. Tree.
Explore the EMUC25 scientific programme now to know more.
Have your say
Prof. Stenzl emphasised “EMUC25’s scientific content is always an amalgamation of the latest literature and developments in the field of uro-oncology, discussed with the delegates by the various players in the field of uro-oncology. “
Dr. Castro added, “Key opinion leaders, seasoned experts, and younger colleagues may have different perspectives and at EMUC, we listen to these voices. EMUC is also an excellent stage to present research in an international and interdisciplinary setting.
“Furthermore, several sessions and courses that take place in smaller groups are designed to offer participants opportunities to have their say. There is ample time for discussions, interaction, and networking, such as during the Poster Session, which is one of my favourite sessions,” concluded Dr. Castro.
Discover more about EMUC25 here. Interested in presenting at the congress? Check out the information on abstract submission.
If you would like to attend EMUC25 as a delegate, register now to take advantage of special rates.